Rapport therapeutics to present at upcoming epilepsy medical conferences

Boston and san diego, sept. 05, 2024 (globe newswire) -- rapport therapeutics, inc. (nasdaq: rapp), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system (cns) disorders, today announced presentations at two upcoming medical conferences: the international league against epilepsy (ilae) 15th annual european epilepsy congress (eec) in rome, italy, september 7-11, 2024, and the 2024 epilepsy foundation pipeline conference in atlanta, ga., september 25-26, 2024.
RAPP Ratings Summary
RAPP Quant Ranking